术前口服葡萄糖负荷后生长激素矛盾反应预测肢端肥大症低复发风险
这项在2家三级中心开展的回顾性观察研究纳入254例经手术治愈的肢端肥大症患者,所有患者术前均行口服葡萄糖耐量试验(OGTT)。以90分钟内生长激素峰值与基线比值≥120%定义矛盾反应(GH-Par),该反应见于87例(34.3%)。多因素分析显示矛盾反应与低复发风险显著相关(HR 0.18,95% CI 0.05-0.63;P = .007)。
要点
- 术前OGTT中生长激素矛盾反应见于34.3%的患者。
- 矛盾反应组复发3例(3.4%),非矛盾反应组复发20例(12.0%)。
- 矛盾反应与低复发风险显著相关(HR 0.18,95% CI 0.05-0.63)。
核心结论
- 术前OGTT中生长激素矛盾反应预测初次手术治愈后较低的疾病复发风险。
- 生长激素对OGTT的反应模式有助于预测肢端肥大症患者的长期结局。
研究设计与样本
- 回顾性观察研究,在2家三级中心开展。
- 纳入254例经手术治愈的肢端肥大症患者,所有患者均在诊断时、垂体手术前接受OGTT。
- 以90分钟内生长激素峰值与基线比值≥120%区分矛盾反应(GH-Par)与非矛盾反应(GH-NPar)。
- 采用Cox分析探究OGTT矛盾生长激素反应与疾病复发风险的关系。
主要发现
- OGTT矛盾生长激素反应见于87例患者(34.3%,即GH-Par组)。
- GH-Par组复发3例(3.4%),GH-NPar组复发20例(12.0%)。
- 多因素分析中,OGTT矛盾生长激素反应与低复发风险显著相关(HR 0.18,95% CI 0.05-0.63;P = .007)。
- 诊断时基线生长激素水平是唯一其他与疾病复发风险相关的变量(HR 1.58,95% CI 1.01-2.47;P = .04)。
关键数值与推荐
- 矛盾反应定义:OGTT后90分钟内生长激素峰值与基线比值≥120%。
临床怎么用
- 术前OGTT的生长激素反应模式可用于预测肢端肥大症患者的长期结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: A paradoxical growth hormone (GH) response to oral glucose load (oral glucose tolerance test [OGTT]) in acromegaly is associated with a milder phenotype. OBJECTIVE: To study whether the GH response to the OGTT predicts the risk of recurrence after initial surgical cure. METHODS: Retrospective, observational study at 2 tertiary care centers. We investigated 254 patients with acromegaly who were cured by surgery. All patients underwent an OGTT at diagnosis before pituitary surgery. A peak to basal GH ratio ≥120% within 90 minutes was used to distinguish paradoxical (GH-Par) from nonparadoxical responses (GH-NPar) in patients with acromegaly. Cox analysis was used to investigate whether the paradoxical GH response to OGTT was associated with the risk of disease recurrence. RESULTS: A paradoxical GH response to OGTT occurred in 87 patients (34.3%, termed GH-Par group). Recurrence of acromegaly occurred in 3 patients in the GH-Par group (3.4%) and in 20 patients in the GH-NPar group (12.0%). In the multivariate analysis, the paradoxical GH response to OGTT was significantly associated with a low risk of recurrence (HR 0.18, 95% CI 0.05-0.63; P = .007). Basal GH level at diagnosis was the only other variable associated with the risk of disease recurrence (HR 1.58, 95% CI 1.01-2.47; P = .04). CONCLUSION: Our study demonstrates that a paradoxical GH response to OGTT in the preoperative setting predicts a lower risk of disease recurrence after initial surgical cure. The pattern of GH responsiveness to OGTT is, therefore, useful to predict the long-term outcome of patients with acromegaly.
引用
- Losa M, Garbin E, Calcagnile R, et al. The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a Low Risk of Recurrence in Acromegaly. J Clin Endocrinol Metab. 2025. PMID: 38878276. doi:10.1210/clinem/dgae410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。